CLINICAL_TRIALS trial_result · 2021-02-23

Clinical Trial Update: Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. [Phase 4]

Summary

Phase 4 trial evaluating the effect of selexipag on daily life physical activity in patients with pulmonary arterial hypertension; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2021-02-23